• The effects of excluding treatments from network meta-analysis

    May 1, 2013, 00:00

  • New Personalized Health Care Approach- Engaging Prostate Cancer Patients, Providers, And Payers

    May 1, 2013, 00:00

  • Surgery and biologic use pattern for patients with crohn's disease who initiated tnf antagonists in a managed care setting in the United States

    May 1, 2013, 00:00

  • The lower and upper limits of an incremental cost-effectiveness ratio associated with the efficiency frontier- A case of HIV/AIDS prevention and treatment

    May 1, 2013, 00:00

  • Cost Of Lost Productivity Due To Prostate Cancer- Evidence From Us National Survey Data

    May 1, 2013, 00:00

  • Copyright/Subscription

    May 1, 2013, 00:00

  • Lessons Learned From The Dedicated Oncology Drug Review Process In Canada

    May 1, 2013, 00:00

  • Preferences of Appalachian women for interventions strategies in a mobile mammography program

    May 1, 2013, 00:00

  • Evidence On Safety Of Metal-On-Metal Hip Resurfacing Arthroplasty

    May 1, 2013, 00:00

  • A Multi-Country Physician Survey On Patient Eligibility And Use Of Biologics In Rheumatoid Arthritis (Ra), Ankylosing Spondylitis (As) And Psoriatic Arthritis (Psa) In European Union (Eu)

    May 1, 2013, 00:00

  • Effect Of Insurance Coverage On Health-Care Expenditures Among Patients With Arthritis

    May 1, 2013, 00:00

  • Cost-Effectiveness Of Linaclotide For The Treatment Of Adult Patients In The Us With Irritable Bowel Syndrome With Constipation

    May 1, 2013, 00:00

  • A Contingent Valuation Survey Of User Financial Incentives For Health Behaviour Change

    May 1, 2013, 00:00

  • Treatment options in obesity- Is clinical development keeping up with an expanding population?

    May 1, 2013, 00:00

  • The expected value of sample information from the pharmaceutical perspective under conditions of value based pricing

    May 1, 2013, 00:00

  • Antipsychotic use and risk of pneumonia in elderly nursing home residents- A propensity-matched study

    May 1, 2013, 00:00

  • Cost-Effectiveness Analysis Of The Use Of Oncotype Dx To Guide Adjuvant Chemotherapy Decisions In Breast Cancer Patients In Mexico

    May 1, 2013, 00:00

  • Impact Of Health, Social, Lifestyle, And Economic Factors On Life Expectancy In Oecd Countries

    May 1, 2013, 00:00

  • The association of burn injuries and Pseudoephedrine sales

    May 1, 2013, 00:00

  • A systemic review- The burden of tuberculosis in asia

    May 1, 2013, 00:00

  • Cost Analysis Of Pars Plana Vitrectomy For The Treatment Of Symptomatic Vitreomacular Adhesion- A Bottom-Up Costing Perspective

    May 1, 2013, 00:00

  • Published Budget Impact Analyses In The United States- Are They (MIS)Informing Decision Makers?

    May 1, 2013, 00:00

  • Euroqol (EQ-5D) health utility scores in post-traumatic stress disorder (PTSD) patients- Results from a doubly randomized preference trial (DRPT)

    May 1, 2013, 00:00

  • Economic impact of switching from metoprolol to nebivolol for hypertension treatment- A retrospective database analysis

    May 1, 2013, 00:00

  • Budget impact model assessment of the costs of converting dialysis patients with a high pill burden on sevelamer to lanthanum carbonate

    May 1, 2013, 00:00

  • Opioid analgesics utilization in us children- A retrospective database analysis

    May 1, 2013, 00:00

  • Does An Eczema Diagnosis In Children Under The Age Of Three Predict A Severe Asthma Diagnosis- A Uk Retrospective Analysis?

    May 1, 2013, 00:00

  • Pharmacoeconomics- Need To Implement As A Tool For Drug Reimbursement In India

    May 1, 2013, 00:00

  • First-line use of calcipotriene/betamethasone dipropionate combination products for the treatment of plaque psoriasis is associated with lower health care utilization and cost

    May 1, 2013, 00:00

  • Economic burden of acute coronary syndrome in a geographically distributed population from 2006 to 2011 in the United States

    May 1, 2013, 00:00

  • A novel approach to ranking parameter uncertainty in one-way sensitivity analysis- What tornado diagrams are missing

    May 1, 2013, 00:00

  • Patient-Reported Quality Of Life And Dyspnea Among Copd Patients With Nighttime And/Or Early Morning Symptoms

    May 1, 2013, 00:00

  • Empirical Comparison Of Discrete Choice Experiment And Best-Worst Scaling To Estimate Stakeholders' Risk Tolerance For Hip Replacement Surgery

    May 1, 2013, 00:00

  • Variation In Cost-Related Medication Non-Compliance With Functional Deficiency And Frequency Of Hospitalization Among US Elderly

    May 1, 2013, 00:00

  • To Identify Comorbid Depression In Diabetes Patients And Comparing The Differences In Use Of Health Care Services In Diabetic Patients With And Without Comorbid Depression

    May 1, 2013, 00:00

  • Structuring Criteria In Multi-Criteria Decision Models For Benefit/Risk Assessment Of Biologics In Juvenile Arthritis

    May 1, 2013, 00:00

  • Reimbursement and market access of multiple sclerosis products in the United States

    May 1, 2013, 00:00

  • Prevalence Of Anti-Diabetic And Antilipidemic Medications In Children And Adolescents Treated With Atypical Antipsychotics In A Virginia Medicaid Population

    May 1, 2013, 00:00

  • Antibiotic prescribing patterns for community acquired pneumonia in hospitalized patients- A retrospective pilot study from delhi, india

    May 1, 2013, 00:00

  • Exploring The Real World Setting Of Chronic Kidney Disease Patient And Physician Behaviors Across Countries- Disease-Specific Programmes

    May 1, 2013, 00:00

  • The economic burden of acute coronary syndrome- Health care and productivity costs

    May 1, 2013, 00:00

  • Prevalence of commercially insured acupuncture and chiropractic use among patients with chronic inflammation or pain diagnoses

    May 1, 2013, 00:00

  • Health Care Costs And Clinical Outcomes Associated With Rates Of Sulfonylurea Use By Physicians

    May 1, 2013, 00:00

  • Patient-Reported Outcomes (Pros) In Diabetes Clinical Trials

    May 1, 2013, 00:00

  • Comparison Of Diagnosis Based Comorbidity Indices To Predict High Cost Copd Patients Prospectively

    May 1, 2013, 00:00

  • Costs Of Adult Immunization Paid In Different Settings

    May 1, 2013, 00:00

  • Is a picture worth a thousand words? the development of a clinician and patient reported photonumeric guide to assess scar severity

    May 1, 2013, 00:00

  • Consequences of the reduction of alcohol consumption on patient's reported outcomes with the use of nalmefene

    May 1, 2013, 00:00

  • Using the weighted interval midpoint estimator (wime) to estimate a population mean from interval data

    May 1, 2013, 00:00

  • Estimated public health impact of nationwide vaccination of infants with 7-valent pneumococcal conjugate vaccine (pcv7) in China

    May 1, 2013, 00:00

  • Patient And Physician Characteristics Associated With Therapeutic Duplication Of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) In South Korea

    May 1, 2013, 00:00

  • Defining clinically meaningful changes for the patient perception of intensity of urgency scale (PPIUS) in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)

    May 1, 2013, 00:00

  • Patterns Of Care, Costs And Outcomes Of Chest Pain Patients Within Two Years Of Initial Visits To The ER

    May 1, 2013, 00:00

  • Comparative analysis of direct cost studies on ankylosing spondylitis (AS) in Turkey

    May 1, 2013, 00:00

  • Patient Reported Outcome Instruments In (Idiopathic) Chronic Cough

    May 1, 2013, 00:00

  • Short-Term Relationships Between Electronic Health Record System Integrity In Emergency Departments (ED) And Health Care Resource Utilization

    May 1, 2013, 00:00

  • Mapping and analyzing stakeholders in china's essential drug operation system by using circular model- Who we should deal with next?

    May 1, 2013, 00:00

  • Claims data algorithms for identifying incident breast cancer (BC) cases and cancer disease stage- a critical review of the literature

    May 1, 2013, 00:00

  • Examination of patient preferences- subgroup comparisons of time trade-off and standard gamble results

    May 1, 2013, 00:00

  • European ex-factory price development for global pharmaceutical companies in the context of the international price reference (ipr) framework. Impact of the german health care reform (amnog) on the european price development for innovative ...

    May 1, 2013, 00:00

  • Evaluation Of The Pharmacy Budget Impact Of Alogliptin Plus Pioglitazone Fixed Dose Combination In The Treatment Of Type-2 Diabetes Mellitus

    May 1, 2013, 00:00

  • Chronic hepatitis c, genotype 1 in the era of direct antiviral agents- Is it time to skip the biopsy and treat everyone?

    May 1, 2013, 00:00

  • Health care resource utilization and costs in patients initiating natalizumab therapy for multiple sclerosis in the United States

    May 1, 2013, 00:00

  • Representing uncertainty of expert opinion in health technology assessment through the use of subjective probabilities

    May 1, 2013, 00:00

  • Uninsured Chronic Hepatitis C Patients And Their Cost Implications Under The Affordable Care Act

    May 1, 2013, 00:00

  • Household Expenditure On Pediatric Atopic Dermatitis Across 12 Countries In The Asia Pacific Region

    May 1, 2013, 00:00

  • Developing A New Model Of Copd- From Conceptualisation To Implementation To Validation

    May 1, 2013, 00:00

  • Evaluating the cost-effectiveness of multicomponent rehabilitation guidelines

    May 1, 2013, 00:00

  • Content validity of the facit-fatigue in patients with iron deficiency anemia

    May 1, 2013, 00:00

  • Impact Of Bone Metastases (Bm) On The Humanistic Burden In Patients With Castration-Resistant Prostate Cancer (Crpc)

    May 1, 2013, 00:00

  • Trends in buprenorphine and methadone sales and utilization in the United States, 1997-2012

    May 1, 2013, 00:00

  • Using parametric survival curves to estimate progression free survival in a netowrk meta-analyis of treatments for chronic lymphocytic leukemia

    May 1, 2013, 00:00

  • The economic burden of chronic kidney disease in China

    May 1, 2013, 00:00

  • Assessing drug costs for use in comparative effectiveness research

    May 1, 2013, 00:00

  • Assessment Of Adherence To Inhaled Corticosteroid Treatment For Asthma- A Cross-Sectional Study From Delhi, India

    May 1, 2013, 00:00

  • Understanding The Psoriasis Patient Perspective- Using A Combination Of Qualitative And Quantitative Analyses To Explore And Describe Symptoms, Impacts, And Treatment-Related Experiences Across The Course Of Disease

    May 1, 2013, 00:00

  • How low can we go?--making meaningful inferences from small samples

    May 1, 2013, 00:00

  • Cost effectiveness analysis of ticagrelor in the treatment of patients with acute coronary syndrome in Mexico- Outcomes for specific groups

    May 1, 2013, 00:00

  • A Cross-Sectional, Hybrid, Patient Survey And Chart Review Study Design To Assess Patterns Of Care, Patient Reported Outcomes, And Quality Of Life In Patients With Chronic Obstructive Pulmonary Disease (Copd)

    May 1, 2013, 00:00

  • Direct medical costs of diabetic complications in the United States

    May 1, 2013, 00:00

  • The Psychometric Properties Of The Malay Version Of The Brief Questionnaire On Smoking Urges

    May 1, 2013, 00:00

  • Gender Differences In Health-Care Related Expenditures For Patients With Arthritis In The United States

    May 1, 2013, 00:00

  • Impact of sports on children with haemophilia in terms of their health status, health-related quality of life and physical performance

    May 1, 2013, 00:00

  • Prediction of mortality in the presence of time-depended covariates- An application for health ecomonic projections

    May 1, 2013, 00:00

  • Cost-effectiveness modelling of telemonitoring after discharge from hospital with heart failure

    May 1, 2013, 00:00

  • Impact Of Oral Medication Adherence And Lab Testing On Five-Year Total Medical Costs In A Commercially Insured Diabetic Population

    May 1, 2013, 00:00

  • Surgery And Biologic Use Pattern For Ulcerative Colitis Patients Initiated With Infliximab In A Managed Care Setting In The United States

    May 1, 2013, 00:00

  • Psychometric performance of the nei VFQ-25- recommendations for a modified version of the 25-item national eye institute questionnaire (NEI VFQ-25) based on rasch analysis using clinical trials data across four retinal diseases

    May 1, 2013, 00:00

  • Cholesterol medication adherence improvement in patient centered medical home primary care practices

    May 1, 2013, 00:00

  • Melanoma health care pathways in an italian population

    May 1, 2013, 00:00

  • A meta-analysis of efficacy and safety of prescription opioids, including formulations with tamper-resistant technologies, in non-cancer pain management

    May 1, 2013, 00:00

  • Drivers Of Cost-Effectiveness In Type-2 Diabetes Mellitus

    May 1, 2013, 00:00

  • Characteristics and treatment patterns of medicaid-eligible preschoolers with attention-deficit/hyperactivity disorder

    May 1, 2013, 00:00

  • Exploration of heterogeneity in distributed research network drug safety analyses

    May 1, 2013, 00:00

  • The cost-effectiveness of apixaban in venous thromboembolism prevention in patients undergoing elective total knee or hip replacement in the colombian private sector

    May 1, 2013, 00:00

  • Content validity of the actionable bladder symptom screening tool (ABSST) in non-diabetic females with overactive bladder (OAB) and urgency urinary incontinence (UUI)

    May 1, 2013, 00:00

  • LDL-C level and goal attainment among patients who switch from higher-efficacy lipid lowering therapies to simvastatin

    May 1, 2013, 00:00

  • Cost analysis of kidney trasplantation with different tratment alternatives at different stages within the mexican public health care system

    May 1, 2013, 00:00

  • Incidence of adverse treatment effects in parkinson's disease- Evidence from a large employer population

    May 1, 2013, 00:00

  • Multiple Sclerosis Increases The Risk Of Infections Resulting In A Hospitalization Among Veterans

    May 1, 2013, 00:00

  • Evaluation of health care cost of diabetes with co-morbidities in South India- A cost of illness study

    May 1, 2013, 00:00

  • Determining An Optimal Pricing Strategy For International Differential Pricing- A Theoretic Macroeconomic Approach

    May 1, 2013, 00:00

  • Health Insurance Coverage In The Houston-Galveston Area Under The Patient Protection And Affordable Care Act

    May 1, 2013, 00:00

  • Patient Outcomes Of Hip Resurfacing Compared To Total Hip Arthroplasty- A Systematic Review

    May 1, 2013, 00:00

  • Psychometric Performance Of The Nei Vfq-25- Rasch Analysis Of The Nei Vfq-25 As A Measure Of Patient-Reported Visual Function Across Four Retinal Diseases

    May 1, 2013, 00:00

  • Results from a D-efficient discrete choice experiment design and protocol with choice sets of 3 states each to elicit an EQ-5D-3L value set

    May 1, 2013, 00:00

  • What Payers Want? The Attraction Of The Head-To-Head ControlledTrial

    May 1, 2013, 00:00

  • A Cross Sectional Assessment Of Knowledge Towards Diabetes Mellitus Among Urban Poor Population Of Penang, Malaysia

    May 1, 2013, 00:00

  • Evaluation Of The Clinical Characteristics And Economic Burden Of Veteran Patients Diagnosed With The Hepatitis C Virus In The United States

    May 1, 2013, 00:00

  • The Cost And Productivity Consequences Of Non-Severe Hypoglycaemic Episodes (Nshe) In Patients Treated With Sulfonylurea Or Dpp4 Dual Combination Oral Therapy

    May 1, 2013, 00:00

  • Cost And Health Care Resource Use Of Pneumonia In Patients With Chronic Obstructive Pulmonary Disease (Copd)

    May 1, 2013, 00:00

  • Trend In Economic Burden Of Diabetes In Urban China From 2009 To 2011

    May 1, 2013, 00:00

  • Patient Safety Programme In KBK Districts Of Odisha, India

    May 1, 2013, 00:00

  • Use Of Biologically Based Therapies (Bbts) And Assessment Of Health Related Quality Of Life (Hrqol) Among Malaysian Cancer Patients

    May 1, 2013, 00:00

  • Development of a new patient reported outcome (PRO) measure for acute bacterial skin and skin structure infections (ABSSSI)

    May 1, 2013, 00:00

  • Costs Of Chemotherapy In Hospital And Office-Based Settings- Policy Implications For Cancer Cost Control

    May 1, 2013, 00:00

  • Health Care Resource Utilization And Cost Of Medicare Patients With Non-Small Cell Lung Cancer (Nsclc)

    May 1, 2013, 00:00

  • Effect Of Ascorbic Acid On Blood Lead Levels Among School Going Adolescents In Karachi- A Cluster Randomized Trial

    May 1, 2013, 00:00

  • Patient-level simulation modeling for economic evaluations- Opportunities and challenges in a practical setting

    May 1, 2013, 00:00

  • Cost Analysis Of Antibiotics Utilization In Respiratory Tract Infection Using Prescribing Indicators

    May 1, 2013, 00:00

  • Estimating the payer-specific excess medical costs of opioid abuse in the United States

    May 1, 2013, 00:00

  • National trends in psychotropic medications use among children with attention deficit hyperactivity disorder (ADHD) in the United States

    May 1, 2013, 00:00

  • Clinical effectiveness and cost-effectiveness of renal denervation for resistant hypertension

    May 1, 2013, 00:00

  • Cost Of Outbreak Of Meningococcal Disease In A Colombian Caribbean City, 2012

    May 1, 2013, 00:00

  • The Prevalence Of Opioid-Related Major Potential Drug-Drug Interactions And Their Impact On Health Care Costs

    May 1, 2013, 00:00

  • Bayesian mixed treatment comparison (MTC)- A novel method to demonstrate equivalence and non-inferiority

    May 1, 2013, 00:00

  • A solution for under-diagnosed post-menopause- Probabilistic linkage of claims and registry data

    May 1, 2013, 00:00

  • Generating distributions and data- evaluating online, freeware options for health economic models

    May 1, 2013, 00:00

  • Cost-Effectiveness And Cost-Utility Analyses Of Fixed-Dose Combination Of Naproxen And Esomeprazole Magnesium For Osteoarthritis Patients At Risk Of Developing Gastric Or Duodenal Ulcer

    May 1, 2013, 00:00

  • The effect of redesigned computerized drug-drug interaction alerts on medication errors and prescribing efficiency

    May 1, 2013, 00:00

  • Evaluation of health related quality of life outcomes among patients with schizophrenia switched to lurasidone from other antipsychotics

    May 1, 2013, 00:00

  • Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients- A retrospective cost analysis

    May 1, 2013, 00:00

  • Examination Of University Students' Intention To Utilize Emergency Contraception Using The Theory Of Planned Behavior

    May 1, 2013, 00:00

  • A Qualitative Exploration Of Perceptions Towards Pharmaceutical Price War Among Community Pharmacies In The State Of Penang, Malaysia

    May 1, 2013, 00:00

  • Burden Of Disease Of Osteoarthritis In Russia- Results From 2011 National Health And Wellness Survey (Nhws)

    May 1, 2013, 00:00

  • Using A HA-CMC Barrier To Avoid Pelvic Or Abdominal Adhesion- Cost-Benefit Advantages In A Private Health Care Setting

    May 1, 2013, 00:00

  • Time and motion study design- Handling variability and confounding of results

    May 1, 2013, 00:00

  • Association between cardiovascular biomarkers levels and cigarette smoking among current smokers, past smokers and non smokers using nhanes 2007-2010

    May 1, 2013, 00:00

  • Determining the current state-of-play for variants of the ‘short form' health-related quality of life instrument in spinal cord injury- A systematic literature review

    May 1, 2013, 00:00

  • Health-related quality of life (HRQOL) in colorectal cancer patients who finish their treatment in a tertiary hospital

    May 1, 2013, 00:00

  • Hospitalization Resource Use and Costs Before and After TIA and Stroke- Results from a Population-Based Cohort Study (OXVASC)

    Mar 1, 2013, 00:00

  • Assessing the Determinants of the Potential for Cost-Effectiveness Over Time- The Empirical Case of COPD

    Mar 1, 2013, 00:00

  • An Expert on Every Street Corner? Methods for Eliciting Distributions in Geographically Dispersed Opinion Pools

    Mar 1, 2013, 00:00

  • Comparative Incidence and Health Care Costs of Medically Attended Adverse Effects among U.S. Medicaid HIV Patients on Atazanavir- or Darunavir-Based Antiretroviral Therapy

    Mar 1, 2013, 00:00

  • Cost-Effectiveness of a Program to Eliminate Disparities in Pneumococcal Vaccination Rates in Elderly Minority Populations- An Exploratory Analysis

    Mar 1, 2013, 00:00

  • Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States

    Mar 1, 2013, 00:00

  • Editorial Board

    Mar 1, 2013, 00:00

  • Patient Preferences for Biologic Agents in Rheumatoid Arthritis- A Discrete-Choice Experiment

    Mar 1, 2013, 00:00

  • Table of Contents

    Mar 1, 2013, 00:00

  • Progression-Free Survival with Fulvestrant 500 mg and Alternative Endocrine Therapies as Second-Line Treatment for Advanced Breast Cancer- A Network Meta-Analysis with Parametric Survival Models

    Mar 1, 2013, 00:00

  • The Cost-Effectiveness of the Levonorgestrel-Releasing Intrauterine System for the Treatment of Idiopathic Heavy Menstrual Bleeding in the United States

    Mar 1, 2013, 00:00

  • Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire Scores in Patients with Colorectal Cancer

    Mar 1, 2013, 00:00

  • Cost-Effectiveness of Enhancing Adherence to Therapy with Blood Pressure–Lowering Drugs in the Setting of Primary Cardiovascular Prevention

    Mar 1, 2013, 00:00

  • Instructions for Authors

    Mar 1, 2013, 00:00

  • Cost-Effectiveness of Cetuximab, Cetuximab Plus Irinotecan, and Panitumumab for Third and Further Lines of Treatment for KRAS Wild-Type Patients with Metastatic Colorectal Cancer

    Mar 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Early versus Late Total Hip Replacement in Italy

    Mar 1, 2013, 00:00

  • Copyright/Subscription

    Mar 1, 2013, 00:00

  • Response about Rank Reversal

    Mar 1, 2013, 00:00

  • The Cost-Effectiveness of a Novel SIAscopic Diagnostic Aid for the Management of Pigmented Skin Lesions in Primary Care- A Decision-Analytic Model

    Mar 1, 2013, 00:00

  • The Comparison of Trial Data–Based and Registry Data–Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach

    Mar 1, 2013, 00:00

  • The Cost-Effectiveness of Duloxetine in Chronic Low Back Pain- A US Private Payer Perspective

    Mar 1, 2013, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration- A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

    Mar 1, 2013, 00:00

  • Economic Measurement of Medical Errors Using a Hospital Claims Database

    Mar 1, 2013, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

    Mar 1, 2013, 00:00

  • Improving the Quality of Papers Published in Pharmacoeconomics and Outcomes Research

    Mar 1, 2013, 00:00

  • Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder

    Mar 1, 2013, 00:00

  • Erratum

    Mar 1, 2013, 00:00

  • Quality of Life in the First 6 Weeks Following Laparoscopic and Open Colorectal Surgery

    Mar 1, 2013, 00:00

  • Evaluating the Impact of Unmeasured Confounding with Internal Validation Data- An Example Cost Evaluation in Type 2 Diabetes

    Mar 1, 2013, 00:00

  • Evidence Synthesis Assumes Additivity on the Scale of Measurement- Response to “Rank Reversal in Indirect Comparisons” by Norton et al.

    Mar 1, 2013, 00:00

  • Understanding the Costs of Care for Cystic Fibrosis- An Analysis by Age and Health State

    Mar 1, 2013, 00:00

  • Need for Speed- An Efficient Algorithm for Calculation of Single-Parameter Expected Value of Partial Perfect Information

    Mar 1, 2013, 00:00

  • Copyright/Subscription

    Jan 1, 2013, 00:00

  • Consumer Preferences for Health and Nonhealth Outcomes of Health Promotion- Results from a Discrete Choice Experiment

    Jan 1, 2013, 00:00

  • Which Health-Related Quality-of-Life Outcome When Planning Randomized Trials- Disease-Specific or Generic, or Both? A Common Factor Model

    Jan 1, 2013, 00:00

  • Sustaining Universal Health Coverage- The Interaction of Social, Political, and Economic Sustainability

    Jan 1, 2013, 00:00

  • Cost-Effectiveness of Gene-Expression Profiling for Tumor-Site Origin

    Jan 1, 2013, 00:00

  • Instructions for Authors

    Jan 1, 2013, 00:00

  • Responsiveness of the EQ-5D Health-Related Quality-of-Life Instrument in Assessing Low Back Pain

    Jan 1, 2013, 00:00

  • Transparent Interactive Decision Interrogator—Reply to Letter to the Editor by Michael Coory

    Jan 1, 2013, 00:00

  • Cost-Effectiveness Analysis- Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists

    Jan 1, 2013, 00:00

  • Core Domains for a Person-Focused Outcome Measurement System in Cancer (PROMS-Cancer Core) for Routine Care- A Scoping Review and Canadian Delphi Consensus

    Jan 1, 2013, 00:00

  • Reviewer Acknowledgment

    Jan 1, 2013, 00:00

  • Turning the Spotlight on Experimental Design in Discrete Choice Experiments—A Focus on Pragmatic Approaches in Health

    Jan 1, 2013, 00:00

  • Cost-Effectiveness of Interventions for Reducing Road Traffic Injuries Related to Driving under the Influence of Alcohol

    Jan 1, 2013, 00:00

  • Multidomain Patient-Reported Outcomes of Irritable Bowel Syndrome- Exploring Person-Centered Perspectives to Better Understand Symptom Severity Scores

    Jan 1, 2013, 00:00

  • The Importance of Values in Shaping How Health Systems Governance and Management Can Support Universal Health Coverage

    Jan 1, 2013, 00:00

  • TIDI Addresses Uncertainty But Not Indeterminism

    Jan 1, 2013, 00:00

  • ERRATUM

    Jan 1, 2013, 00:00

  • Editorial Board

    Jan 1, 2013, 00:00

  • Is Management Essential to Improving the Performance and Sustainability of Health Care Systems and Organizations? A Systematic Review and a Roadmap for Future Studies

    Jan 1, 2013, 00:00

  • Assessing the Added Value of Health Technologies- Reconciling Different Perspectives

    Jan 1, 2013, 00:00

  • An International Survey of the Public Engagement Practices of Health Technology Assessment Organizations

    Jan 1, 2013, 00:00

  • Instructions for Authors

    Jan 1, 2013, 00:00

  • Setting the Scene- The Challenges of Universal Health Coverage and the Contribution of Management Education

    Jan 1, 2013, 00:00

  • Copyright/Subscription

    Jan 1, 2013, 00:00

  • The Optimality of Different Strategies for Supplemental Staging of Non–Small-Cell Lung Cancer- A Health Economic Decision Analysis

    Jan 1, 2013, 00:00

  • Understanding the Impact of Global Trade Liberalization on Health Systems Pursuing Universal Health Coverage

    Jan 1, 2013, 00:00

  • Using Resource Use Logs to Reduce the Amount of Missing Data in Economic Evaluations Alongside Trials

    Jan 1, 2013, 00:00

  • Economic Appraisal of a Community-Wide Cardiovascular Health Awareness Program

    Jan 1, 2013, 00:00

  • Identifying Differential Responders and Their Characteristics in Clinical Trials- Innovative Methods for Analyzing Longitudinal Data

    Jan 1, 2013, 00:00

  • Detecting Changes in Patient Treatment Satisfaction with Medicines- The SATMED-Q

    Jan 1, 2013, 00:00

  • Adding Decision Models to Systematic Reviews- Informing a Framework for Deciding When and How to Do So

    Jan 1, 2013, 00:00

  • The Effects of Diabetes, Hypertension, Asthma, Heart Disease, and Stroke on Quality-Adjusted Life Expectancy

    Jan 1, 2013, 00:00

  • Mapping from Disease-Specific to Generic Health-Related Quality-of-Life Scales- A Common Factor Model

    Jan 1, 2013, 00:00

  • Rejoinder to Commentary- When Mapping Treatment Effects from Disease-Specific to Generic Scales, Ordinary Least Squares Regression Underestimates the Benefits of Treatment

    Jan 1, 2013, 00:00

  • Universal Health Coverage- A Quest for All Countries But under Threat in Some

    Jan 1, 2013, 00:00

  • Some Comments on Mapping from Disease-Specific to Generic Health-Related Quality-of-Life Scales

    Jan 1, 2013, 00:00

  • Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine- Results from the American Migraine Prevalence and Prevention (AMPP) Study

    Jan 1, 2013, 00:00

  • Constructing Experimental Designs for Discrete-Choice Experiments- Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force

    Jan 1, 2013, 00:00

  • Code of Ethics

    Jan 1, 2013, 00:00

  • The International Society for Pharmacoeconomics and Outcomes Research

    Jan 1, 2013, 00:00

  • Table of Contents

    Jan 1, 2013, 00:00

  • Universal Health Coverage—Big Thinking versus Big Data

    Jan 1, 2013, 00:00

  • Table of Contents

    Jan 1, 2013, 00:00

  • Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments

    Jan 1, 2013, 00:00

  • Economic Efficiency of Countries’ Clinical Review Processes and Competitiveness on the Market of Human Experimentation

    Jan 1, 2013, 00:00

  • Assessing the Impact of Privatizing Public Hospitals in Three American States- Implications for Universal Health Coverage

    Jan 1, 2013, 00:00

  • Editorial Board

    Jan 1, 2013, 00:00

  • A Quantitative Benefit-Risk Analysis of Isoniazid for Treatment of Latent Tuberculosis Infection Using Incremental Benefit Framework

    Jan 1, 2013, 00:00

  • Binary Choice Health State Valuation and Mode of Administration- Head-to-Head Comparison of Online and CAPI

    Jan 1, 2013, 00:00

  • Whole Disease Modeling to Inform Resource Allocation Decisions in Cancer- A Methodological Framework

    Dec 1, 2012, 00:00

  • The Use of Qualitative Methods in Developing the Descriptive Systems of Preference-Based Measures of Health-Related Quality of Life for Use in Economic Evaluation

    Dec 1, 2012, 00:00

  • Table of Contents

    Dec 1, 2012, 00:00

  • Unidimensional 12-Item Zarit Caregiver Burden Interview for the Assessment of Dementia Caregivers’ Burden Obtained by Item Response Theory

    Dec 1, 2012, 00:00

  • What Is Wrong with Orphan Drug Policies? Suggestions for Ways Forward

    Dec 1, 2012, 00:00

  • The Use and Performance of Productivity Scales to Evaluate Presenteeism in Mood Disorders

    Dec 1, 2012, 00:00

  • Measuring and Valuing Health Benefits for Economic Evaluation in Adolescence- An Assessment of the Practicality and Validity of the Child Health Utility 9D in the Australian Adolescent Population

    Dec 1, 2012, 00:00

  • What Is Wrong with Orphan Drug Policies?

    Dec 1, 2012, 00:00

  • Comparisons of Food and Drug Administration and European Medicines Agency Risk Management Implementation for Recent Pharmaceutical Approvals- Report of the International Society for Pharmacoeconomics and Outcomes Research Risk Benefit Manag ...

    Dec 1, 2012, 00:00

  • Work Productivity in Relapsing Multiple Sclerosis- Associations with Disability, Depression, Fatigue, Anxiety, Cognition, and Health-Related Quality of Life

    Dec 1, 2012, 00:00

  • Cost-Effectiveness of Using a Molecular Diagnostic Test to Improve Preoperative Diagnosis of Thyroid Cancer

    Dec 1, 2012, 00:00

  • Rank Reversal in Indirect Comparisons

    Dec 1, 2012, 00:00

  • Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research- A Report of the ISPOR Personalized Medicine Special Interest Group

    Dec 1, 2012, 00:00

  • Instructions for Authors

    Dec 1, 2012, 00:00

  • Comparing 15D and SF-6D Performance in Fragility Wrist and Hip Fracture Patients in a Two-Year Follow-Up Case-Control Study

    Dec 1, 2012, 00:00

  • Inquiry into the Relationship between Equity Weights and the Value of the QALY

    Dec 1, 2012, 00:00

  • Budget Impact Analysis of HIV Testing in the VA Healthcare System

    Dec 1, 2012, 00:00

  • Demonstrating the Burden of Hypoglycemia on Patients' Quality of Life in Diabetes Clinical Trials- Measurement Considerations for Hypoglycemia

    Dec 1, 2012, 00:00

  • Editorial Board

    Dec 1, 2012, 00:00

  • Multiple Criteria Decision Analysis for Health Technology Assessment

    Dec 1, 2012, 00:00

  • Measuring Health-Related Quality of Life in Leukemia- The Functional Assessment of Cancer Therapy – Leukemia (FACT-Leu) Questionnaire

    Dec 1, 2012, 00:00

  • Contingent Valuation Scenarios for Chronic Illnesses- The Case of Childhood Asthma

    Dec 1, 2012, 00:00

  • Copyright/Subscription

    Dec 1, 2012, 00:00

  • Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values- Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D

    Dec 1, 2012, 00:00

  • Development of the Shortness of Breath with Daily Activities Questionnaire (SOBDA)

    Dec 1, 2012, 00:00

  • A Multigene Prognostic Assay for Selection of Adjuvant Chemotherapy in Patients with T3, Stage II Colon Cancer- Impact on Quality-Adjusted Life Expectancy and Costs

    Dec 1, 2012, 00:00

  • Patient-Level Hospital Costs and Length of Stay After Conventional Versus Minimally Invasive Total Hip Replacement- A Propensity-Matched Analysis

    Dec 1, 2012, 00:00

  • Preferences for Managing Symptoms of Differing Severity- A Discrete Choice Experiment

    Dec 1, 2012, 00:00

  • Comparison of Generic, Condition-Specific, and Mapped Health State Utility Values for Multiple Myeloma Cancer

    Dec 1, 2012, 00:00

  • PDB35 Evaluation of the Long Term Economic Impact of Improving Hba1C in Type 2 Diabetes Patients in Saudi Arabia

    Nov 1, 2012, 00:00

  • PMS48 Tocilizumab in Methotrexate-Intolerant or Contraindicated Patients – A Cost-Utility Model for the UK

    Nov 1, 2012, 00:00

  • PHP162 Review of NICE's Technology Appraisal Recommendations

    Nov 1, 2012, 00:00

  • PHP63 Integrated Medication Reconciliation Model in Computerized Physician Order Entry (CPOE) System

    Nov 1, 2012, 00:00

  • PRS25 Cost Analysis of Omalizumab Use in Patients With Severe Uncontrolled Asthma Within the Mexican Public Health Care System

    Nov 1, 2012, 00:00

  • PHP46 Burden of Herpes Zoster in Population with Compromised Immune System in South Korea

    Nov 1, 2012, 00:00

  • PCN3 Quality-Adjusted Survival in Patients With Wild-Type (WT) KRASs Metastatic Colorectal Cancer (mCRC) Receiving First-Line Therapy With Panitumumab Plus FOLFOX Versus FOLFOX Alone

    Nov 1, 2012, 00:00

  • PSS30 Cosmeceutiqol- A Dermo-Cosmetic Quality-of-Life Assessment Tool

    Nov 1, 2012, 00:00

  • PDB34 Economic Evaluation of Treating Diabetes Patients According to Guidelines in South-Western Ontario, Canada

    Nov 1, 2012, 00:00

  • PHP79 Stakeholders's Views Regarding the Impact of Financial Crisis on the Pharmaceutical Market in Greece

    Nov 1, 2012, 00:00

  • PDB32 Diabetic Foot Syndrome Hospitalization Costs in Poland

    Nov 1, 2012, 00:00

  • PIH13 The Costs of Unintended Pregnancy in Russia

    Nov 1, 2012, 00:00

  • PDB6 Real-World Comparative Effectiveness Analysis of Patients Initiating Injectable Treatments for Type 2 Diabetes Mellitus (T2DM)- Pilot Data From the Initiator Study

    Nov 1, 2012, 00:00

  • PCN125 Cost of Presenteeism Due to Cancer in Poland

    Nov 1, 2012, 00:00

  • PRS46 Health Care Resource Use of Patients With Cystic Fibrosis (CF) in the UK

    Nov 1, 2012, 00:00

  • PHS55 Inequalities and Avoidable Costs of Imaging Test in the Diagnosis and Monitoring of Patients With Stroke in the Canary Islands

    Nov 1, 2012, 00:00

  • PRM14 European Assessment of the Validity of the QALY Outcome Measure- Results From the Experiment Conducted by the Echoutcome Project

    Nov 1, 2012, 00:00

  • PHP159 Proposed and Actual Bureaucratic Burden of HTA Submissions to the Industry- Case Studies from Germany and UK

    Nov 1, 2012, 00:00

  • PMH45 Health-Related Quality of Life Patient-Reported Outcomes in Schizophrenia

    Nov 1, 2012, 00:00

  • PMH32 Modelling the Cost and Effectiveness Outcomes Associated With Different Sequences for the Treatment of Chronic Schizophrenia- An Economic Evaluation of Paliperidone Palmitate

    Nov 1, 2012, 00:00

  • PHP20 Analysis of How Payers Incorporate Health Economic Analyses Into Coverage and HTA Decisions for Personalized Medicine Diagnostics

    Nov 1, 2012, 00:00

  • PMS62 Nominal Group Technique to Select Attributes for Discrete Choice Experiments

    Nov 1, 2012, 00:00

  • PCN9 Modeling Lifetime Effectiveness of Denosumab Versus Placebo in Men With Castration Resistant Prostate Cancer (CRPC) at High Risk of Developing Bone Metastasis (BM)

    Nov 1, 2012, 00:00

  • PND49 The Measurement of Quality of Life in Children With Cystic Fibrosis With Using Russian Version of Health Utility Index (HUI) Questionnaire

    Nov 1, 2012, 00:00

  • PIN11 Pharmacotherapy of Acute Bronchitis in Clinics- Results of Pharmacoepidemical Research

    Nov 1, 2012, 00:00

  • PSY14 Cost- Effectiveness Analysis of Pregabalin in the Treatment of Fibromyalgia

    Nov 1, 2012, 00:00

  • PCN19 Cost-Effectiveness Analysis of Temsirolimus in Patients With Poor Risk Renal-Cell Carcinoma

    Nov 1, 2012, 00:00

  • PMH9 Antidepressant Prescription Patterns Among Patients With Major Depression Based on Claims Database in Japan

    Nov 1, 2012, 00:00

  • PMH36 Time Trade-Off (TTO) Analysis to Elicit Health State Utilities Related to Long Acting Treatments in Schizophrenia

    Nov 1, 2012, 00:00

  • PRM164 Ensuring the Value of a Medical Device Innovation Prior to Market Launch

    Nov 1, 2012, 00:00

  • PHP65 Quality of Care- Reference and Counter Reference from Family Physicians and Rheumatologists' Perspectives– A Pilot Study

    Nov 1, 2012, 00:00

  • PHP96 National Health Insurance Claims Database As a Valuable Source of Information for Health Technology Assessment in Taiwan

    Nov 1, 2012, 00:00

  • PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma

    Nov 1, 2012, 00:00

  • PRM28 A Refined Comorbidity Index for the Studies of Health Related Quality of Life

    Nov 1, 2012, 00:00

  • PRM21 Communicating to Decision Makers the Parameter Uncertainty in the IQWiG Efficiency Frontier Approach

    Nov 1, 2012, 00:00

  • PRM92 Exploratory Mapping of the LupusQol to the SF-6D

    Nov 1, 2012, 00:00

  • PRM9 Using Propensity Score Matching to Estimate the Resource Burden of Hospital Acquired Clostridium Difficile Infection in England

    Nov 1, 2012, 00:00

  • PRM43 Roles and Selection of Comparative Treatment(s) in the Assessment of New Drug Reimbursement and Pricing Application to Taiwan National Health Insurance (NHI)

    Nov 1, 2012, 00:00

  • PCN127 Policy Maker, Please Carefully Consider Your Needs- Does Outcomes Research of Bortezomib for Advanced Multiple Myeloma Reduce Uncertainty?

    Nov 1, 2012, 00:00

  • PR1 Comparison of Cancer Drug Prices in the United States and the Uk

    Nov 1, 2012, 00:00

  • PCN154 Are Population-Based Registries a Suitable Tool for Outcomes Research in Cancer? Experiences from Four Registries

    Nov 1, 2012, 00:00

  • PRM106 Examination of Preferences Elicited From the General Public- Comparisons of Results From the Time Trade-Off and Standard Gamble Instruments

    Nov 1, 2012, 00:00

  • PHS12 Meta-Analysis of Parkinson's Disease Risk With Hypertension, Serum Total Cholesterol, and Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PSY20 Cost-Effectiveness of Prophylaxis With an Anti-Inhibitor Complex Concentrate in Patients With Haemophilia and Inhibitors- Results From Pro-Feiba Study

    Nov 1, 2012, 00:00

  • PHP83 Community Pharmacist'S Perceptions Towards the Quality of Locally Manufactured Generic Medicines- A Descriptive Study from Malaysia

    Nov 1, 2012, 00:00

  • PHP104 Hypertension Control and Doctors' Knowledge, Attitude and Practices on Malaysian Clinical Practice Guidelines on Management of Hypertension (CPG 2008) at a Tertiary Hospital

    Nov 1, 2012, 00:00

  • PDB11 Efficacy of Exentaide in Type 2 Diabetes Mellitus in a Local Hospital in Taiwan- a Pilot Study

    Nov 1, 2012, 00:00

  • PMS14 Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis in China

    Nov 1, 2012, 00:00

  • PIN69 Cost Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in Malaysia

    Nov 1, 2012, 00:00

  • PMD72 The Use of Multi-Criteria Decision Analysis to Elicit Colorectal Cancer Screening Preferences

    Nov 1, 2012, 00:00

  • PIH10 Utility Values for Use in Health Care Decision Making for Older Frail Adults

    Nov 1, 2012, 00:00

  • PDB21 Chart Audit and Budget Impact Analysis of Pasireotide Versus Second-Line Therapies in the Treatment of Cushing's Disease in Germany

    Nov 1, 2012, 00:00

  • PRM67 The Use of Health Economic Models in Hungarian Health Technology Assessment

    Nov 1, 2012, 00:00

  • PUK5 Employment Rates and Indirect Costs in Patients With End-Stage Renal Disease- Differences Between Modalities of Renal Replacement Therapy

    Nov 1, 2012, 00:00

  • PND10 Economic Evaluation of Interferon âeta-1A Versus Interferon âeta-1B in the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) in Iran

    Nov 1, 2012, 00:00

  • CN4 Inpatient Treatment Patterns and Health Care Expenditures for Hepatocellular Carcinoma Among Population With Urban Basic Health Insurance in China

    Nov 1, 2012, 00:00

  • PHP191 Impact of a Financial Risk-Sharing Scheme on Budget-Impact Estimations- A Game-Theoretic Approach

    Nov 1, 2012, 00:00

  • PHP43 The High Cost of Treating Cancer- Do Manufacturer Pricing Policies Take Affordability Into Account?

    Nov 1, 2012, 00:00

  • PIN16 Tuberculosis Treatment Outcomes in Patients With and Without Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PCN38 Impact of Biomarker Testing on Clinical and Economic Outcomes in Advanced Cancer Treatment

    Nov 1, 2012, 00:00

  • PRM45 Are Minimal Clinically Important Difference Measures (MCIDs) Relevant for Survival Outcomes? Introducing the MCID-CAC

    Nov 1, 2012, 00:00

  • PCV56 Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at LDL Cholesterol Treatment Goal in Brazil

    Nov 1, 2012, 00:00

  • PMS15 An Economic Evaluation of Denosumab in the Treatment of Postmenopausal Osteoporosis in a Taiwanese Setting

    Nov 1, 2012, 00:00

  • PCN80 Modelling the Cost-Effectiveness of Ipilimumab for Previously-Treated, Metastatic Melanoma

    Nov 1, 2012, 00:00

  • PHS20 Cost Associated to the Management of Inappropriate Shocks in Patients With an Implantable Cardioverter Defibrillator – Cardina Study

    Nov 1, 2012, 00:00

  • PHP86 Outcomes and Factors Associated with Hospital Mortality in Patients with Impaired Left Ventricular Function Undergoing Coronary Bypass Grafting; Where Do We Stand?

    Nov 1, 2012, 00:00

  • PRM102 Validation of the Russian Version of Schizophrenia Quality of Life Questionnaire (S-QoL)

    Nov 1, 2012, 00:00

  • PMH39 Identifying Disease-Defining Concepts Using Spontaneous and Probed Responses From Semi-Structured Qualitative Interviews in Patients With Major Depressive Disorder

    Nov 1, 2012, 00:00

  • PRM95 Does the Cat Questionnaire Produce Similar Results When Self- or Interviewer-Administered?

    Nov 1, 2012, 00:00

  • PMD50 Cost-Effectiveness Analysis of Four Validated Techniques of Accelerated Partial Breast Irradiation for the Treatment of Early-Stage Breast Cancer- Spanish Public Health System Standard Estimations

    Nov 1, 2012, 00:00

  • PCN16 Comparison of the Efficacy and Cost of Novel Targeted Cancer Therapies

    Nov 1, 2012, 00:00

  • PRM35 Prevalence of Rare Diseases – A Special Challenge for Benefit Assessment and Health Economics

    Nov 1, 2012, 00:00

  • PHP149 Health Technology Assessment Evidence Criteria- What Types of Evidence Should Be Presented for Products Used to Screen for Disease in the United States?

    Nov 1, 2012, 00:00

  • RE3 How Will the New NHS Changes in England Impact the Implementation of Risk-Sharing Schemes for Oncology Treatments?

    Nov 1, 2012, 00:00

  • PHP60 Assessment of Geographic Pharmacy Accessibility in Qom (Iran)- a Geographic Information System Analysis

    Nov 1, 2012, 00:00

  • PCV96 Relationship Between Inflammation and Patient Functioning in Cardiovascular Disease- A Review of the Literature

    Nov 1, 2012, 00:00

  • PGI39 Budegt Impact Analysis of HCV Therapy Cost After Boceprevir Addition to Standard Therapeutic Regime

    Nov 1, 2012, 00:00

  • PHS72 Quality of Life With Type2 Diabetes- Translation and Validation of Indian Version of MDQ

    Nov 1, 2012, 00:00

  • PRS1 The Use of Montelukast and Neuropsychiatric Disturbances Among Pediatric Asthmatics- A Nested Case-Control Study

    Nov 1, 2012, 00:00

  • PIN25 Health and Economic Benefits of Avoiding Hospital Pen Moves for Dairy Cattle in the United States

    Nov 1, 2012, 00:00

  • PCN59 Patterns of Clinical Management and Resource Utilization for Postmenopausal Hormone Receptor–Positive HER2-Negative (HR+ HER2–) Advanced Breast Cancer (ABC) in Europe

    Nov 1, 2012, 00:00

  • PIN46 Pharmacoeconomic Evaluation of the Introduction of Universal Varicella Vaccination in Italy

    Nov 1, 2012, 00:00

  • PHP101 The Implementation of Diagnostic Related Groups (DRGs) in Gree One Move Forward to Efficiency

    Nov 1, 2012, 00:00

  • PMS70 Utilization of Pain Medications Among Osteoarthritis Patients Who Initiated Duloxetine and Standard of Care for Pain Management

    Nov 1, 2012, 00:00

  • PHP102 Patient Satisfaction with Pharmacies Condition

    Nov 1, 2012, 00:00

  • PIN61 The Cost-Utility of Telaprevir in Combination With Peginterfeon Alpha and Ribavirin (PR) as Compared to the Combination Boceprevir With PR and to PR Alone in the Management of Chronic Hepatitis C in the Netherlands

    Nov 1, 2012, 00:00

  • PCV55 A Cost-Effectiveness Analysis of Coralan® (Ivabradine) Plus Standard Care Versus Standard Care Alone in Chronic Heart Failure

    Nov 1, 2012, 00:00

  • PIN10 Epidemiology and Economic Burden of Pneumomococcal Disease in Older Adults in Taiwan

    Nov 1, 2012, 00:00

  • PHP42 Do Macroeconomic Conditions Explain Drug Price Variations Across Countries? A Cross-Sectional Analysis

    Nov 1, 2012, 00:00

  • PSY19 A Cost-Consequence Analysis of Patient Self-Management Versus Physician-Managed Monitoring of Long-Term Oral Anticoagulation Therapy in Canada

    Nov 1, 2012, 00:00

  • PGI35 Health-Related Quality of Life in Patients With Haemophilia and Inhibitors on Prophylaxis With Anti-Inhibitor Complex Concentrate- Results From the Pro-Feiba Study

    Nov 1, 2012, 00:00

  • PRM121 Burden of Osteoarthritis- Development of a Questionnaire

    Nov 1, 2012, 00:00

  • PHP97 Identifying Modeling Factors Influencing Coverage Decisions by Nice in 10 Single Technology Appraisals (STA) of Expensive Drugs

    Nov 1, 2012, 00:00

  • PCN72 Modeling the Survival Loss in Patients With Philadelphia Chromosome Positive (Ph+) Chronic Phase Chronic Myeloid Leukemia (CML-CP) Switched from Imatinib Mesylate to a Generic Copy

    Nov 1, 2012, 00:00

  • PND22 Descriptive Analysis of the Direct Costs of Relapsing-Remitting Multiple Sclerosis in the Mexican Setting

    Nov 1, 2012, 00:00

  • PRM160 A New Value-Based Pricing Framework for the Optimal Pricing of Pharmaceutical Assets

    Nov 1, 2012, 00:00

  • PHP25 The Pharmaceutical Industry as Partner in Integrated Care Contracts - Potential Improvement or Vain Attempt? First Experiences from Germany

    Nov 1, 2012, 00:00

  • PRM40 Applying Stratification on Time to Overcome Time-Varying Covariates Effects in Cox Proportional Hazards Models

    Nov 1, 2012, 00:00

  • PGI2 Infliximab Reduces the Risk of Surgical Interventions and Hospitalization in Patients With Inflammatory Bowel Disease

    Nov 1, 2012, 00:00

  • PRM17 Cost-Utility Analysis of Donepezil for the Treatment of Alzheimer's Disease in Thailand

    Nov 1, 2012, 00:00

  • PHP190 Global Pharmaceutical Risk-Sharing Agreement Trends in 2011 and 2012- Slowing Down?

    Nov 1, 2012, 00:00

  • PSS35 Frequency of Ranibizumab Injections for the Treatment of Wet Age-Related Macular Degeneration- Canadian Real-World Utilization Data

    Nov 1, 2012, 00:00

  • PHS94 Involvement of CNS Specialists in Health Care Provision for Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)- New Data from Nordbaden, Germany, 2003 - 2009

    Nov 1, 2012, 00:00

  • PHP89 Market Access of Drugs in Fran Evolution or Revolution?

    Nov 1, 2012, 00:00

  • PND20 12-Month Cost of Illness Study of Moderate Alzheimer'S Disease Patients in Spain- The Evocost Study

    Nov 1, 2012, 00:00

  • PHP77 Pharmaceutical Benefit Advisory Committee Acceptability Threshold Results 2005-2011

    Nov 1, 2012, 00:00

  • PHS79 The Analysis of the Formulary Committees in Kazakhstani Regions

    Nov 1, 2012, 00:00

  • PHP175 Economic Performance and Epidemiological Transition in Mexico

    Nov 1, 2012, 00:00

  • PIN76 Health Related Quality of Life of HIV Infected Intravenous Drug Users

    Nov 1, 2012, 00:00

  • Ex2 An Observation on the Trend of Outpatient Clinic Utilization and Numbers of Medical Prescription Given in Taiwan Elderly Between 1997 and 2010

    Nov 1, 2012, 00:00

  • PHS29 Cost of Treating Patients With Obstructive Sleep Apnea/Hypopnea Sydrome in the Sotiria Chest Hospital in Greece

    Nov 1, 2012, 00:00

  • PSY8 Budget Impact Analysis of Ustekinumab for the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Thailand

    Nov 1, 2012, 00:00

  • PGI1 The Effectiveness and Tolerability of Combined Treatment With Peginterferon Alpha-2a or Alpha-2b and Ribavirin in the Treatment of Patients With Chronic Hepatitis C- Results Based on the Nationwide Hepatitis Registry in Japan

    Nov 1, 2012, 00:00

  • PMD36 Cost-Analysis of PCR Guided Pre-Emptive Antibiotic Treatment of S.aureus-infections- An Analytic Decision Model

    Nov 1, 2012, 00:00

  • QL1 EQ-5D-5L Valuation Project for the Spanish Population – A Descriptive Overview and Preliminary Results

    Nov 1, 2012, 00:00

  • PMH7 Analyses of Switching and Combination Use of Antidepressants in Young Swedish Adults

    Nov 1, 2012, 00:00

  • PCN146 Trends in Computed Tomography Use in Canada- Low-Dose Ionizing Radiation and the Potential Related Cancer Risk

    Nov 1, 2012, 00:00

  • PHP6 The Study of Antihyperglycemic Drug Use Patterns and the Toward Clinical Excellence Network'S Diabetes (TCEN DM) Indicators in Patients with Type 2 Diabetes Mellitus at Samutsakhon Hospital

    Nov 1, 2012, 00:00

  • PND48 Health State Values in Alzheimer'S Disease – Baseline Results From a Large Prospective Observational Study in Three European Countries (GERAS)

    Nov 1, 2012, 00:00

  • PMH52 Health Care Resource Utilization and Costs for Patients With Anorexia Nervosa, Bulimia Nervosa, and Binge Eating Disorder

    Nov 1, 2012, 00:00

  • PRM144 Cardiologists' Knowledge and Awareness of Guidelines for Medical Device Safety and Product Risk Management

    Nov 1, 2012, 00:00

  • PCN110 Differences in Health-Related Quality of Life Between Children Treated for Acute Lymphoblastic Leukemia (ALL) on Dana Farber Cancer Institute (DFCI) Protocols

    Nov 1, 2012, 00:00

  • PCN151 HTAs for the Deadliest Diseases- What Can We Learn from Multi-National Comparisons of Oncology and Cardiology Health Technology Assessments?

    Nov 1, 2012, 00:00

  • PIH40 What Do Health Economists Expect from Their Employer- Results from an On-Line Survey in Germany

    Nov 1, 2012, 00:00

  • PDB68 Physician Beliefs About Insulin Pens Versus Vials, Therapy Choice Factors, and Patient Characteristics Among Elderly Type 2 Diabetes Patients

    Nov 1, 2012, 00:00

  • PHP24 Should Pharmacist Remuneration Systems in Europe Be Reformed in Order to Increase Generic Medicine Dispensing?

    Nov 1, 2012, 00:00

  • PSU20 A Cost-Effectiveness Analysis of Minimally Invasive Versus Open Surgery Techniques for Lumbar Spine Fusion

    Nov 1, 2012, 00:00

  • PMH6 Evolution of Antidepressant Efficacy Over Time- Illustration With Escitalopram

    Nov 1, 2012, 00:00

  • PHP169 Comparing the Hungarian Methodological Guideline for Conducting Economic Evaluation of Health Care Intervention with European Guidelines

    Nov 1, 2012, 00:00

  • PMD18 Introduction of Novel Biomarker Testing for Ovarian Cancer- Budget Impact Analysis for an Italian Regional Health Care Service

    Nov 1, 2012, 00:00

  • PCN144 Access to Cancer Interventions Across the UK- To What Extent Does SMC Advice Agree with Nice'S End-of-Life Therapies?

    Nov 1, 2012, 00:00

  • PUK11 Cost-Effectivness Analysis of Once Daily Versus Twice Daily Tacrolimus in Post-Renal Transplant Patients in the Czech Republic

    Nov 1, 2012, 00:00

  • PHP124 Comparison of HTA Dossier Requirements Across Europe

    Nov 1, 2012, 00:00

  • PIN48 Cost-Efectiveness Analysis of Darunavir Versus Atazanavir, Each in Combination With Emtricitabine and Tenofovir, for the Management of Naive Anti-Retroviral HIV Infected Patients, Under the Belgian Social Security Perspective

    Nov 1, 2012, 00:00

  • Table of Contents

    Nov 1, 2012, 00:00

  • PRS10 Assessment of Knowledge Regarding Tuberculosis Among General Population in North East Libya

    Nov 1, 2012, 00:00

  • PIH15 Prescribing Cost of Enzymes Over a Two-Year Period Using a Medical Insurance Claims Database

    Nov 1, 2012, 00:00

  • PRM163 The Use of Expected Value of Perfect Information Analysis Within Economic Evaluations and Health Technology Assessments in the UK

    Nov 1, 2012, 00:00

  • PHP179 Evaluation of Prescribing Practices of Clinicians in Government Teaching Hospital in Pakistan

    Nov 1, 2012, 00:00

  • PND41 The Cost-Effectiveness of Buccolam for the Treatment of Prolonged, Acute, Convulsive Epileptic Seizures in Spain

    Nov 1, 2012, 00:00

  • PHP158 Cross-Funtional Challenges in the Preparation of a Benefit Dossier

    Nov 1, 2012, 00:00

  • PUK8 4-Year Incidence and Costs of Hospitalized Complications Within Kidney Transplant Patients in France

    Nov 1, 2012, 00:00

  • PND71 Predictors of Treatment Class Choice in Parkinson's Disease

    Nov 1, 2012, 00:00

  • PMD85 Agent-Based Cardiovascular Disease Model for India

    Nov 1, 2012, 00:00

  • PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoV ...

    Nov 1, 2012, 00:00

  • PRM8 Costing Issue in Pharmacoeconomic Studies from the Perspective of Singapore Public Health Care Provider

    Nov 1, 2012, 00:00

  • PMS34 Cost-Effectiveness Analysis of Bemiparin as Prophylaxis for Venous Thromboembolism in Total Knee Replacement Surgery in Mexico

    Nov 1, 2012, 00:00

  • PHP9 Assessment of Diagnostic Need for Magnetic Resonance Imaging in Medicare Patients with Pacemaker Implants

    Nov 1, 2012, 00:00

  • PRS10 An Analysis of Reported Pneumonia Deaths in Malaysia

    Nov 1, 2012, 00:00

  • PHP70 A 3-Year Follow-Up Study on National Health Insurance Reimbursements Among Atrial Fibrillation Patients With/Without Stroke in Taiwan- A Population-Based Study

    Nov 1, 2012, 00:00
  • «
  • 111
  • 112
  • 113 (current)
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »